Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Down 21.8% in December

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 212,900 shares, a decline of 21.8% from the December 15th total of 272,100 shares. Currently, 5.0% of the shares of the company are short sold. Based on an average daily volume of 2,920,000 shares, the short-interest ratio is presently 0.1 days.

Silo Pharma Stock Up 13.1 %

Shares of SILO traded up $0.23 during mid-day trading on Thursday, hitting $1.98. 575,845 shares of the company’s stock were exchanged, compared to its average volume of 17,854,480. The stock’s 50-day simple moving average is $1.08 and its 200-day simple moving average is $1.24. Silo Pharma has a 52 week low of $0.77 and a 52 week high of $4.50.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.